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Abstract
Objectives Coronary artery volume indexed to left myocardial mass (CAVi), derived from coronary computed tomography
angiography (CCTA), has been proposed as an indicator of diffuse atherosclerosis. We investigated the association of CAVi
with quantitative flow parameters and its ability to predict ischemia as derived from 13N-ammonia positron emission tomography
myocardial perfusion imaging (PET-MPI).
Methods Sixty patients who underwent hybrid CCTA/PET-MPI due to suspected CAD were retrospectively included. CAVi
was defined as total coronary artery lumen volume over myocardial mass, both derived from CCTA. From PET-MPI, quanti-
tative stress and rest myocardial blood flow (MBF) andmyocardial flow reserve (MFR) were obtained and correlated with CAVi,
and semi-quantitative perfusion images were analyzed for the presence of ischemia. Harrell’s c-statistic and net reclassification
improvement (NRI) analysis were performed to evaluate the incremental value of CAVi over the CCTA model (i.e., stenosis
> 50% and > 70%).
Results CAVi correlated moderately with stress MBF and MFR (R = 0.50, p < 0.001, and R = 0.39, p = 0.002). Mean stress
MBF and MFR were lower in patients with low (i.e., ≤ 20.2 mm3/g, n = 24) versus high (i.e., > 20.2 mm3/g, n = 36) CAVi
(p < 0.001 for both comparisons). CAVi was independently associated with abnormal stress MBF (OR 0.90, 95% CI 0.82–
0.998, p = 0.045). CAVi increased the predictive ability of the CCTA model for abnormal stress MBF and ischemia (c-
statistic 0.763 versus 0.596, pdiff < 0.05 and 0.770 versus 0.645, pdiff < 0.05, NRI 0.84, p = 0.001 and 0.96, p < 0.001,
respectively).
Conclusions CAVi exhibits incremental value to predict both abnormal stress MBF and ischemia over CCTA alone.
Key Points
• Coronary artery volume indexed to left myocardial mass (CAVi), derived from coronary computed tomography angiography
(CCTA), is correlated with myocardial blood flow indices derived from 13N-ammonia positron emission tomography
myocardial perfusion imaging.
• CAVi is independently associated with abnormal stress myocardial blood flow.
• CAVi provides incremental diagnostic value over CCTA for both abnormal stress MBF and ischemia.
Keywords Computed tomography angiography . Positron emission tomography .Myocardial ischemia
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Coronary computed tomography angiography (CCTA) is a
valuable tool for the non-invasive anatomic assessment of
coronary atherosclerosis due to its excellent negative predic-
tive value. A limitation of CCTA is its moderate positive
predictive value [1, 2].
Consequently, there is growing interest in parameters de-
rived from anatomy, which exhibit the ability to assess the
functional relevance of coronary stenosis. Among them, cor-
onary artery lumen volume indexed to left ventricular mass
(CAVi) has been recently proposed as a novel CCTA-derived
marker for non-obstructive but flow-limiting coronary athero-
sclerosis with prognostic value [3]. Furthermore, CAVi has
been associated with an abnormal fractional flow reserve
(FFR), as derived from invasive coronary angiography [4].
Aside from focal coronary artery stenosis, diffuse atheroscle-
rosis in epicardial vessels constitutes an additional mechanism
affecting myocardial blood flow (MBF) [5, 6]. As CAVi is not
solely dependent on focal stenosis but rather reflects changes
in coronary artery lumen among the entire coronary tree, it
may be a potential surrogate marker for changes in global
and/or regional MBF.
Positron emission tomography myocardial perfusion imag-
ing (PET-MPI) is considered the gold standard for the non-
invasive quantitative assessment of MBF (in milliliters per
gram per minute) with independent prognostic value [7].
Potential association between CAVi and quantitative PET-
derived parameters would further corroborate the validity of
a concept pertaining the flow-limiting effects of diffuse
atherosclerosis.
In the present study, we aimed to investigate the association
of CAVi with quantitative flow parameters and its ability to
predict ischemia as derived from 13N-ammonia PET-MPI.
Materials and methods
Study population
We retrospectively identified patients who underwent both
CCTA and PET-MPI within a maximum interval of 90 days
at our institution due to suspected coronary artery disease
(CAD). Patients with a history of previous percutaneous cor-
onary intervention (PCI) or coronary artery bypass grafting
(CABG), inadequate CT image quality, resulting in ≥ 1 non-
evaluable coronary segments, or incomplete segmentation of
the left ventricular mass, were excluded.
Baseline demographic and clinical characteristics and tra-
ditional cardiovascular risk factors were recorded in all pa-
tients. The study protocol was approved by the local ethics
committee (BASEC-Nr. 2016-00177 and 2018-00508), and
the need for written informed consent was waived.
CCTA data acquisition and assessment
All patients were pre-treated with 2.5 mg sublingual
spray of isosorbide dinitrate and, if necessary, with up
to 30 mg intravenous metoprolol to achieve a heart rate
< 65 bpm.
Contrast-enhanced CCTA was performed either on 64-
slice (n = 20; LightSpeed VCT or Discovery HD 750, both
GEHealthcare) or a 256-slice scanner (n = 40, CTRevolution,
GE Healthcare) CT scanner, using axial scanning with pro-
spective ECG triggering, as previously described [8, 9]. In
brief, collimation was 64 × 0.625 mm with an axial resolution
of 0.23 × 0.23 mm, z-coverage 40 mm with an increment of
35 mm and gantry rotation time 350 ms for the 64-slice scan-
ner, collimation 256 × 0.625 mm with an axial resolution of
0.23 × 0.23 mm, z-coverage 160 mm and gantry rotation time
280 ms for the 256-slice scanner. The smallest possible win-
dow at one distinct mid-diastolic phase of the RR cycle (i.e.,
setting the ECG trigger at 75%) was chosen.
All vessels were assessed for the presence of atherosclerot-
ic plaques. Separate analyses were performed for coronary
stenosis > 50% and > 70% [10].
Assessment of CAVi
The coronary arterial tree was segmented and extracted
from the imaging data and analyzed using dedicated
software (CardIQ Xpress-Auto Coronary Analysis, GE
Healthcare). The three main arteries (left main stem
and left anterior descending artery, left circumflex, and
right coronary artery) and their branches were segment-
ed distally up to a minimal vessel diameter of 1.5 mm,
in order to ensure adequate distal contrast opacification
and subsequent reliable volume calculations. The soft-
ware automatically identified and contoured the lumen
and different plaque components based on scan-specific
attenuation thresholds in each individual scan [11].
Automatic contouring was manually corrected where re-
quired. The coronary artery volume (i.e., lumen) was
then calculated in mm3. The software tool has already
been validated versus intravascular ultrasound [12]. For
the left ventricular (LV) mass measurements, endocardi-
al and epicardial contours were automatically drawn and
manually adjusted where needed. LV mass was calculat-
ed in gram using dedicated software (CardIQ Function
Xpress, GE Healthcare). Lastly, indexed coronary vol-
ume for each patient was calculated by dividing the
total coronary volume by the LV mass, resulting in
the CAVi. The measurement can be acquired in
10 min per patient on average (range 5 to 15 min)
and the methodology yields excellent intra- and
interreader agreement (0.99 and 0.98, both p < 0.001,
respectively).[3]
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13N-ammonia PET imaging and data analysis
PET acquisition and analysis protocol have been previously
described [13, 14]. In brief, all patients underwent 13N-ammo-
nia at rest and during adenosine-induced stress at a standard
rate (0.14 mg/min/kg). Images were acquired either on a
Discovery (LS/RX) PET/CT scanner or on an Advance PET
scanner (both GE Healthcare).
Quantitative global MBF and myocardial flow reserve
(MFR) were calculated using commercially available software
(PMOD version 3.7; PMOD Technologies Ltd.). In brief, a
volume of interest was placed in the blood-pool of the left and
the right ventricle. Consequently, myocardial and blood-pool
time-activity curves (TAC) were obtained from dynamic
frames, corrected for radioisotope decay. Stress and rest
MBF values were estimated by model fitting of the blood-
pool and myocardial TACs in stress and rest, respectively.
The left ventricular wall was divided into 17 segments [13,
15, 16]. MFR was accordingly calculated for each segment as
the ratio of stress to rest MBF [13, 14]. AnMFR < 2 or a stress
MBF < 1.79 ml/g/min were considered abnormal [16, 17].
Lastly, regional MBF and MFR values of the 17 segments
were recorded for each coronary territory based on standard
distribution models [15].
Semi-quantitative segmental normalized relative 13N-am-
monia uptake was recorded according to the guidelines [18].
Presence of ischemia was defined as a summed segmental
difference score (SDS) ≥ 2 [18].
Statistical analysis
Continuous variables were expressed as mean ± standard de-
viation while categorical variables as absolute numbers and
frequencies. Comparison of continuous variables was per-
formed using either Student’s t test or Mann-Whitney U test
as appropriate. Assessment for normality of data distribution
was evaluated by the Kolmogorov-Smirnov test. The
Pearson’s correlation coefficient was used to assess the corre-
lation between CAVi and quantitative PET parameters. A
two-tailed p value < 0.05 was considered statistically signifi-
cant. A receiver operator characteristics (ROC) curve analysis
was performed to investigate the performance of CAVi in
predicting ischemia, and the area under the curve (AUC)
was calculated. Consequently, Youden’s index was used to
calculate the optimal cutoff for CAVi. Moreover, multivariate
logistic regression analysis was used to determine whether
there is an independent association of CAVi with stress
MBF and ischemia.
To further investigate the incremental predictive value of
CAVi in predicting abnormal stress MBF or ischemia, the
following models were selected and compared using
Harrell’s c-statistics: Model (1): stenosis > 50%; model (2):
stenosis > 70%; model (3): CAVi; model (4): stenosis > 50%
+ CAVi; model (5): stenosis > 70% + CAVi. Additionally, we
explored the impact of the addition of CAVi as a continuous
variable on a basic model based on CCTA stenosis severity
(i.e., > 50% or > 70%) on integrated discrimination improve-
ment (IDI) and net reclassification improvement index (NRI).
Statistical analysis was performed using SPSS software (ver-
sion 25, IBM), while MedCalc software (MedCalc Software
Ltd.) was used for the comparison of AUCs.
Results
Study population
Details on screening, exclusion, and eligibility for analysis of
the study population are depicted in the study flow chart in
Fig. 1. Sixty patients and 180 vessels were enrolled and ana-
lyzed. The mean heart rate during CCTA scans was 60.3 ±
11.1 bpm. CCTA and PET examinations were performed
within 2 days (interquartile range 0–22). The baseline charac-
teristics of the study population are summarized in Table 1.
CCTA findings
CCTA confirmed > 50% stenosis and > 70% stenosis in at
least one vessel in 44 (73.3%) and 15 (25%) patients, respec-
tively. Vessel-wise, a stenosis > 50% was recorded in 78 ves-
sels (43.3%), resulting in 19 (31.7%), 16 (26.7%), and 9
(11.7%) patients with 1-, 2- and 3-vessel disease, respectively.
Table 1 Baseline
characteristics of the
study population (n = 60)
Clinical characteristics
Age (years) 64 ± 9.8
Gender (male) 43 (72)
BMI (kg/m2) 29 ± 6.6
Cardiovascular risk factors
Arterial hypertension 31 (52)
Diabetes mellitus 6 (10)
Dyslipidemia 35 (58)
Positive family history 16 (27)
Smoking 26 (43)
Clinical symptoms
Typical angina 14 (23)
Atypical angina 10 (17)
Unclear chest pain 12 (20)
Dyspnea 6 (10)
Asymptomatic 14 (23)
Other symptoms 4 (7)
Values given are absolute numbers and
percentages (in brackets) or mean ± stan-
dard deviation. BMI, body mass index
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A stenosis > 70% was recorded in 22 vessels (12.2%). Mean
LV mass and CAVi were 113.3 ± 37.4 g and 21.9 ± 8.5 mm3/
g, respectively. ROC curve analysis of CAVi revealed an
AUC of 0.711 (95% CI 0.561–0.861, p = 0.01) to predict
ischemia. Based on Youden’s index, we identified an optimal
cutoff value of 20.2 mm3/g. A CAVi equal or below this
threshold was classified as low-CAVi (n = 24, 40%) and a
value above this threshold was classified as high-CAVi
(n = 36, 60%).
Correlation of CAVi with 13N-ammonia PET
measurements
Mean stress MBF, rest MBF, and MFR were lower in patients
with low-CAVi, compared to patients with high-CAVi (1.66 ±
0.64 versus 2.32 ± 0.67 ml/min/g, 0.78 ± 0.17 versus 0.93 ±
0.32 ml/min/g and 2.09 ± 0.65 versus 2.56 ± 0.63 ml/min/g,
respectively, p < 0.001 for all comparisons). The proportion of
vessel territories with an abnormal stress MBF or an abnormal
MFR was significantly higher in the low-CAVi group (59.7%
versus 19% and 44.4% versus 18.1%, respectively, p < 0.001
for both comparisons). Interestingly, this was also true for
vessel territories where CCTA did not show any stenosis
> 50% (60% versus 14.3%, p < 0.001 with abnormal stress
MBF and 40% versus 15.9% with abnormal MFR, p = 0.009)
or any stenosis > 70% (57.1% versus 15.2%, p < 0.001 for
abnormal MBF and 39.3% versus 16.2%, p = 0.001 for
abnormal MFR).
There was a moderate correlation between CAVi and re-
gional stress MBF and MFR (R = 0.47 and R = 0.36,
respectively, p < 0.001 for both comparisons, Fig. 2)
There was a moderate correlation between CAVi and global
stress MBF and MFR (R = 0.50, p < 0.001, and R = 0.39, p =
0.002, respectively, Fig. 3). Additionally, the proportion of pa-
tients with abnormal global MFR was higher in the low-CAVi
group (33.3% versus 11.4%, p = 0.04). In the low-CAVi group
(n = 24), 11 (45.8%) patients had abnormal stress MBF in all 3
vessel territories, 2 (8.3%) in 2 vessel territories, 6 (25%) in 1
territory, and 5 (20.8%) had normal stress MBF in all vessel
territories. In contrast, in the high-CAVi group (n = 36), 4
(11.1%) patients showed abnormal stress MBF in all 3 vessel
territories, 3 (8.3%) in 2 vessel territories, 2 (5.5%) in 1 territo-
ry, and 27 (75%) had normal stress MBF in all vessel territories
(chi-square p < 0.001). Similar results were found for the anal-
ysis of MFR: As compared to the high-CAVi group, a larger
proportion of patients in the low-CAVi group had abnormal
MFR values in any of the 3 vessel territories, in 2 vessel terri-
tories, and in 1 vessel territory (25% versus 5.5%, 12.5% versus
8.33%, and 33.3% versus 19.44%, respectively, p = 0.03)
Value of CAVi for abnormal stress MBF and ischemia
prediction
A comparison of the ROC curves revealed that the AUC of
CAVi for abnormal s t ress MBF predic t ion was
larger compared to stenosis > 50% (p = 0.05) and similar with
Fig. 1 Study flow chart
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stenosis > 70% (p = 0.22). Moreover, the addition of CAVi
increased significantly the AUC of the CCTA model, based
on > 50% stenosis (p = 0.007).
Regarding ischemia prediction, there was no difference be-
tween the AUC of CAVi and the AUCs of the CCTA models
(both stenosis > 50% and > 70%, p = 0.42 and p = 0.76,
respectively). However, the addition of CAVi significantly
increased the AUC of the CCTA model, based on > 50%
stenosis (p = 0.03, Table 2 and Fig. 4).
Table 3 summarizes the percentages of the patients correct-
ly reclassified as having abnormal stress MBF or ischemia
after the addition of CAVI on models based on stenosis sever-
ity (either > 50% or > 70%).
In multivariate logistic regression analysis, CAVi was in-
dependently associated with abnormal stress MBF (odds ratio
0.90, 95% CI 0.82–0.998, p = 0.045) but not with ischemia.
Results of the univariate and multivariate logistic regression
analyses are given in Table 4.
Figures 5 and 6 depict two representative cases, one with
low-CAVi and one with high-CAVi, respectively, both with
normal global stress MBF.
Discussion
In the present study, we demonstrate that CAVi (a) correlates
modestly with stress MBF and MFR, as derived from 13N-am-
monia PET-MPI, both in vessel- and patient-based analyses; (b)
it is independently associated with abnormal stress MBF; and
(c) it exhibits incremental predictive value over stenosis sever-
ity for abnormal stress MBF and ischemia prediction.
There are several theories linking CAVi to myocardial per-
fusion. Firstly, according to allometric laws, there is a close
linear relationship between coronary volume and left ventric-
ular mass, verified in animal models [19]. Thus, it can be
hypothesized that there is a critical threshold for coronary
lumen volume per myocardial mass, below which adequate
myocardial perfusion cannot be achieved, particularly in cases
of diffuse—but not necessarily obstructive—coronary athero-
sclerosis. Indeed, De Bruyne et al showed an association be-
tween arteries with diffuse atherosclerosis but angiographic-
ally non-obstructive disease and abnormal FFR [5].
Further supporting this theory, in a recent study, Taylor
et al evaluated for the first time the impact of CAVi on FFR
Fig. 2 Scatterplots demonstrating the association between CAVi and regional stress MBF (panel a) and between CAVi and regional MFR (panel b)
Fig. 3 Scatterplots demonstrating the association between CAVi and global stress MBF (panel a) and between CAVi and global MFR (panel b)
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values. The authors concluded that there is an association
between low-CAVi and positive FFR values in invasive cor-
onary angiography despite the absence of obstructive CAD
[4]. In this study, a slightly lower CAVi cutoff value of
18.57 mm3/g, based on the median, was applied. However,
as there are currently no standardized values for CAVi and
because methods and study populations may vary, we used a
cutoff based on ROC curve to predict ischemia.
A potential correlation of CAVi with qualitative myo-
cardial flow parameters, derived non-invasively from
PET-MPI (stress MBF and MFR), would further corrob-
orate the validity of the basic concept for this theory,
indicating CAVi as a surrogate marker of diffuse ath-
erosclerosis. In a recent study by van Diemen et al [20],
a very weak association was recorded, based on data
derived from 15O-water PET-MPI. Interestingly, a cutoff
of 20.7 mm3/g, very similar to the present study (20.2
mm3/g), was associated with both hyperemic blood flow
and low invasive FFR. Furthermore, in accordance with
our results, a higher ratio of vessel territories with ab-
normal stress MBF or MFR was observed in patients
with low-CAVi. However, the correlations in our study,
based for the first time on data derived from 13N-am-
monia PET-MPI, for both stress MBF and MFR were
stronger (R = 0.47, p < 0.001, and R = 0.36, p < 0.001
versus R = 0.148, p = 0.027, and R = 0.09, p = 0.14,
respectively). Moreover, vessels without obstructive ste-
nosis and either abnormal stress MBF or MFR were
more common in patients with low-CAVi.
Impaired vessel responsiveness to endothelium-
dependent vasodilatation due to diffuse intimal thicken-
ing is a second potential mechanism [4, 21]. Thus, a
low-CAVi as derived from CCTA may be associated
with impaired vasodilatory vessel response to nitroglyc-
erin (which is applied before a CCTA scan) [22]. It
may be hypothesized that CAVi, which is a marker
obtained at the epicardial vessel-level, may be seen as
surrogate marker for the entire coronary circulation,
Table 2 C-statistics of various
models for abnormal stress MBF
and ischemia prediction






1. Stenosis > 50% 0.596†‡ (0.460–0.722) 0.645* 0.561–0.861
2. Stenosis > 70% 0.652# (0.517–0.771) 0.736 0.581–0.891
3. CAVi 0.758‡ (0.629–0.860) 0.711 0.561–0.861
4. Stenosis > 50% + CAVi 0.763† (0.635–0.864) 0.770* 0.636–0.904
5. Stenosis > 70% + CAVi 0.775# (0.647–0.873) 0.782 0.644–0.921
CAVi, coronary artery volume index; CI, confidence interval
† p value for comparison = 0.007
‡ p value for comparison = 0.05
*p value for comparison = 0.03
# p value for comparison = 0.06




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































including the microcirculation. However, only a study
assessing the intra-patient CAVi variability with and
without nitrates could lend further support to the above
theory.
The second important finding of the present study was the
incremental value of CAVi in abnormal stress myocardial
blood flow and ischemia prediction. In fact, the addition of
CAVi significantly improved the predictive value of the
stenosis-based model. This applies in particular when using
the 50% stenosis threshold.
The discrepancy between the anatomic severity and the
functional significance of a stenosis is well documented.
CCTA provides a number of non-invasive parameters to fur-
ther elucidate the potential hemodynamic relevance of a given
lesion. These include transluminal attenuation gradient
(TAG), vulnerable plaque characteristics, and CT-derived
fractional flow reserve (FFRCT). Each technique tool has
shown to feature specific strengths and limitations:
In brief, like CAVi, TAG is assessed solely based on
CCTA-derived anatomy without the need of additional
stress testing or image acquisitions. However, the vali-
dation of TAG against invasive FFR as the standard of
reference has yielded conflicting results [14, 23, 24].
Morphological plaque characteristics indicative of vul-
nerability such as spotty calcifications, low attenuation
areas, eccentric remodeling, or the napkin-ring sign have
been shown to be associated with the presence of ische-
mia as derived from invasive FFR [25]. However, the
absence of morphological vulnerability criteria does not
exclude hemodynamical relevance of a given stenosis,
limiting its negative predictive value. A further limita-
tion arises from the dependence on very high image
quality and spatial resolution [26]. Lastly, FFRCT has
been validated against invasive FFR in prospective stud-
ies, showing incremental diagnostic accuracy compared
to CCTA alone [27]. On the other hand, the remote and
Fig. 5 A 63-year-old male patient who underwent CCTA due to unstable
angina. CCTA demonstrated obstructive CAD with high calcium burden
and intermediate (i.e., 50–70%) stenosis in all three vessels. Global stress
MBF as derived by 13N-ammonia PET was 2.88 ml/g/min. Coronary
volumewas calculated as 1100.6mm3, and LVmass as 126.8 g, resulting
in a CAVi of 8.7 mm3/g (i.e., low-CAVi). PET-MPI revealed ischemia in
the left ventricular lateral wall
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time-consuming segmentation of vessel lumen and the
dependence on very good image quality is currently
limiting its clinical applicability.
The incremental value of CAVi to predict abnormal stress
myocardial blood flow and ischemia suggests the potential
clinical utility of this specific marker. Similarly to TAG and
plaque vulnerability assessment, calculation of CAVi requires
no stress testing nor additional scans and does not extensively
depend on high spatial resolution, as do computational fluid
dynamic calculations, for example, for CT-derived FFR.
Moreover, the calculation can be performed on-site using
commonly available software. Most importantly, the prognos-
tic significance of CAVi has already been shown in a previous
study, hinting at the potential for clinical application [3]. The
validation, however, of exact cutoffs mandates large,
prospective—and most importantly—multi-center and cross-
vendor studies.
Limitations
There are some limitations to the present study. Firstly, the
retrospective nature of this study inherently introduced selec-
tion bias, and the results may have been affected by unmea-
sured confounders.Moreover, we did not apply the previously
described segmentation for MFR (involving only segments
distal to stenosis > 50%) [14]. Instead, we aimed to correlate
the respective regional MFR of a vessel territory defined by
the standard segmentation model to CAVi without, however,
correcting for multiple measurements. Additionally, coronary
lumen volumes were indexed to total myocardial mass, opting
for a patient-phenotype predisposing for myocardial ischemia.
A vessel-based segmentation of CAVi instead, relating a re-
gional coronary artery lumen volume to the fraction of the
myocardial mass subtended by the vessel territory, would re-
quire too many assumptions and may not be reliable [28].
Secondly, although CAVi assesses the vasodilatory response
to nitroglycerin, it does not allow to directly assess the status
of the microcirculation of the patient. Finally, as all CT scans
were prospectively ECG-triggered and acquired at 75% of the
RR-interval, the computed LV mass corresponds to the mid-
diastolic rather than the true end-diastolic mass. However,
mid-diastolic LV mass values have been validated and corre-
late well with the standard assessment of LV mass [29].
Conclusions
CAVi is independently associated with abnormal stress myo-
cardial blood flow. More importantly, CAVi exhibits incre-
mental value to predict abnormal stress MBF and ischemia
over findings from CCTA alone.
Fig. 6 A 57-year-old female who underwent CCTA due to stable angina.
CCTA demonstrated stenosis > 50% in LAD and LCx. Global stress
MBF as derived by 13N-ammonia PET was 2.45 ml/g/min. Coronary
volume was calculated as 1613.3 mm3 and LV mass as 61.60 g, resulting
in a CAVI of 26.2 mm3/g (i.e., high-CAVi). PET-MPI revealed normal
perfusion
Eur Radiol
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